The U.S. Is Quietly Giving A Chinese Billionaire A Monopoly On A New Liver Cancer Drug
Category: POLITICS
It’s the at least second time this year the federal government has proposed giving exclusive rights for taxpayer-funded research to a foreign pharmaceutical giant.
By Alexander C. Kaufman, 2017-08-08